Delta-Hexanolactone
D-Hexanolactone is the lactone of 5-hydroxy-Hexanoic acid. Lactones are internal esters that exist in equilibrium between their closed (lactone) and open (hydroxy acid) forms in an aqueous environment. The lactone/hydroxy acid ratio at equilibrium is pH-dependent, with the closed form being favored at lower pH values, and can be greatly influenced by structural features of the lactone such as the ring size, substituents on the ring and the presence of double bonds within the ring. Many drugs and endogenous compounds are lactones or hydroxy acids and an enzyme capable of catalyzing the interchange between the open and closed forms in vivo colid have pronounced effects upon their biological activity and/or distribution. d-Hexanolactone is the substrate of paraoxonases (PON) in humans. Human PON1 hydrolyzes over 30 different lactones (cyclic esters) and catalyzes the reverse reaction (lactonization) of a broad range of hydroxy acids. Hydroxy acid lactonization or lactone hydrolysis is catalyzed until equilibrium between the open and closed forms is reached. (PMID 15772423 , 12963475 , 12963475 ).
Structure for HMDB00453 (Delta-Hexanolactone)
C6H10O2
114.1424
114.068079564
6-methyloxan-2-one
hexanolactone
823-22-3
RZTOWFMDBDPERY-UHFFFAOYSA-N
This compound belongs to the class of chemical entities known as delta valerolactones. These are cyclic organic compounds containing an oxan-2- one moiety.
Chemical entities
Organic compounds
Organoheterocyclic compounds
Lactones
Delta valerolactones
Aliphatic heteromonocyclic compounds
Not Available
Expected but not Quantified
Not Available
Not Available
Solid
LC-MS/MS Spectrum – Quattro_QQQ 10V, Positive (Annotated)splash10-014i-9000000000-36d0969790fae080b15eView in MoNA
LC-MS/MS Spectrum – Quattro_QQQ 25V, Positive (Annotated)splash10-014i-9000000000-b68dc16317b5e5cd454aView in MoNA
LC-MS/MS Spectrum – Quattro_QQQ 40V, Positive (Annotated)splash10-05fr-9100000000-74433d7dfd6ec3f65493View in MoNA
LC-MS/MS Spectrum – EI-B (HITACHI M-80B) , Positivesplash10-0006-9000000000-91819f2130833f0f1fb2View in MoNA
Predicted LC-MS/MS Spectrum – 10V, Positivesplash10-014i-7900000000-e8d560d4b336564e2ccbView in MoNA
Predicted LC-MS/MS Spectrum – 20V, Positivesplash10-014i-9100000000-65742bbbb910102701f6View in MoNA
Predicted LC-MS/MS Spectrum – 40V, Positivesplash10-0a6u-9000000000-1fe8eea9b95cd214ad44View in MoNA
Predicted LC-MS/MS Spectrum – 10V, Negativesplash10-03di-2900000000-17f45c3a4167b21bd28eView in MoNA
Predicted LC-MS/MS Spectrum – 20V, Negativesplash10-03di-9800000000-fa49d7a801b88ba62245View in MoNA
Predicted LC-MS/MS Spectrum – 40V, Negativesplash10-0006-9000000000-c440f6358807e3ad3227View in MoNA
1H NMR SpectrumNot Available
[1H,13C] 2D NMR SpectrumNot Available
Not Available
Not Available
Not Available
Not Available
None
None
Not Available
Not Available
Not Available
Not Available
FDB008077
Not Available
12649
Not Available
Not Available
Not Available
Not Available
HMDB00453
HMDB00453
5442
13204
Not Available
589927
Product: Niraparib metabolite M1
- Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN: Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res. 2005 Jun;46(6):1239-47. Epub 2005 Mar 16. [PubMed:15772423 ]
- Moser AB, Jones DS, Raymond GV, Moser HW: Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res. 1999 Feb;24(2):187-97. [PubMed:9972864 ]
- Teiber JF, Draganov DI, La Du BN: Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Biochem Pharmacol. 2003 Sep 15;66(6):887-96. [PubMed:12963475 ]